Stock DVAX DYNAVAX TECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Dynavax Technologies Corporation

Equities

DVAX

US2681582019

Delayed Nasdaq
Other stock markets
 03:59:40 2024-05-28 pm EDT 		5-day change 1st Jan Change
11.5 USD +0.97% Intraday chart for Dynavax Technologies Corporation +0.31% -17.78%
May. 24 Dynavax Technologies Corporation Reappoints Ernst & Young LLP as Independent Registered Public Accounting Firm CI
May. 14 Dynavax Technologies Notified by US FDA That Application for Four-Dose Course of Hepatitis B Vaccine Lacks Sufficient Data MT

Evolution of the average Target Price on Dynavax Technologies Corporation

Price target over the last 5 years

History of analyst recommendation changes

089091.RYFIiivv2HkcLKrEj7pPkHpBP0Cwe25fOGKFK-8qnhw.BMccwEe3sRotSdKI4tAo-BUCd22JSQQrCi-0f4dH6E8v7izwXpW6QVReng~6af57484a24de06205d2cd6c990b8a36

Analyst Recommendations on Dynavax Technologies Corporation

Goldman Sachs Initiates Dynavax Technologies at Neutral Rating With $20 Price Target MT
JMP Securities Adjusts Price Target on Dynavax Technologies to $25 From $24, Maintains Market Outperform Rating MT
JMP Securities Trims Price Target on Dynavax Technologies to $24 From $25, Maintains Market Outperform Rating MT
JMP Securities Adjusts Price Target on Dynavax Technologies to $25 From $22, Maintains Market Outperform Rating MT
HC Wainwright Adjusts Price Target on Dynavax Technologies to $27 From $28, Maintains Buy Rating MT
JMP Securities Starts Dynavax Technologies at Market Outperform With $22 Price Target MT
Goldman Sachs Reinstates Dynavax Technologies at Buy With $38 Price Target MT
HC Wainwright Adjusts Price Target on Dynavax Technologies to $28 From $23, Reiterates Buy Rating MT
DYNAVAX TECHNOLOGIES : HC Wainwright Adjusts Dynavax Technologies' Price Target to $23 From $20, Keeps Buy Rating MT
DYNAVAX TECHNOLOGIES : Goldman Sachs Starts Dynavax Technologies at Buy With $19 Price Target MT
DYNAVAX TECHNOLOGIES : HC Wainwright Adjusts Dynavax Technologies' Price Target to $20 From $16, Keeps Buy Rating MT
DYNAVAX TECHNOLOGIES : HC Wainwright Adjusts Dynavax Technologies' Price Target to $14 From $12, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
11.39 USD
Average target price
25.91 USD
Spread / Average Target
+127.50%
High Price Target
29 USD
Spread / Highest target
+154.61%
Low Price Target
20 USD
Spread / Lowest Target
+75.59%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Dynavax Technologies Corporation

Goldman Sachs
JMP Securities
HC Wainwright

Ratings for Dynavax Technologies Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DVAX Stock
  4. Consensus Dynavax Technologies Corporation